Lonza Signs Manufacturing Deal with Immune Pharmaceuticals

06:04 AM | July 19, 2011 | Deepti Ramesh

Lonza says it has signed an exclusive contract for the production of Immune Pharmaceuticals’ (Tel Aviv, Israel) human immunoglobulin monoclonal antibody, Bertilimumab, under investigation for the...